Asia scriptor SUMMUS PHARMA eventu ad Highlight innovations in medicamento partus excipients ex June 24-26 in Shanghai
Xi'an Deli Biochemical Industry, Ltd, A Dux in Pharmaceutical Excipients, erit unveil et secans-Edge hydroxypropylet (HP-β-CD) et Technologies Sulfobutyl Aethe Sinis (SBECD) Technologies ad CPHI Sinis MMXXV (Technologies ad CPHI Sinis MMXXV (Both). Hae Cyclodextrin derivationes sunt, in enhancing medicamento solubility, stabilitatem et bioavailability, addressing discrimine challenges in novae medicamento formula-praesertim in injectables, oncology, et veterinarii medicinae. De res, Asia scriptor maxima pharmaceutical congregatione, convenit ad Shanghai Novum Internationalis EXPO Center (Sniec) a June 24-26.
Amid ortu demanda pro universa medicamento partus systems, Xi'an de Cyclodeextrin Platforms offer transformative solutions:
Hydroxypropyl Retadex: Dat humilis-toxicity solubilization of male aqua-solutum apis, acceleratrice progressionem oris et injectable generica et nova mulgeret.
Tetadex sulfobutyl Aethe sodium: praebet princeps biocompatibility pro parenteral formulae (E.G., antibiotics, antivirals), reducendo renum toxicity et supporting extenditur, release profiles.
Haec excedant align cum CPHI scriptor focus in "Novum qualis productivity," Permeting Drugmakers vincere bioavailability claustra et streamline regulatoria meatus pro global fora.
Claudendo Invitatio:
Xi'an Deli Biochemical Industry Co., Ltd. Est summus tech coeptis specialiter in investigationis & progressionem, productio & venditionesque de Cyclodextrin et ejus derivationes.
Cum suam de instauratione in August XXVII, MCMXCIX, in comitatu est adhaerens ad qualis consilium de "focusing in accessiones, qualis primus, sincera servitium, nititur ad primum-genus, sincerum, certando pro primo-genus '. Post plus XX annis et progressionem et progressionem, in comitatu currently habet products Deli Brand Hydroxypropyl Retadex, Deli Brand Tob Sulfobutyl Aethe Sodium. Et supra products sunt relatus et filed cum FDA.
Ut CyclodExtrins Redefine medicamento partus efficaciam, CPHI praebet ad specimen scaena ad demonstrabo eorum ictum, et invita sociis ad umbraculum e3q10 ad explorandum quomodo Hydroxypropyl Pipeline et Pipeline Pipeline. "
Nam magis notitia:
Visit: CPHI Sinis MMXXV, June 24-26, Sniec Shanghai, Booth E3Q10
Explore: Deli scriptor plena CyclodExtrin Portfolio adhttps://www.delicydextrin.com/
De Xi'an Deli Biochemical Industry Co., Ltd.
Specializing in altus-perficientur pharmaceutical excipients quia MMV, deli pioneers cyclodeextrin-fundatur solutions ad global medicamento innovators, adhaerens ad USP / ep / Chp signa. Eius products enable tutius, magis effective therapeutica trans oncology, injectables et targeted partum.
Circum CPHI Sinis MMXXV:
Co-Sita est PMEC Sinis, hoc praetoriensis eventu (E1-E7, W1-W5 Halls) Covers pharmacum ingredientia, machinery, packaging et biopharma Delegations.
